chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within minutes post vax, the pt developed a 3 cm area of hives at the injection site. The hives resolved. The injection site then became warm and tender for 36 hours. He recovered. The reporter indicated that the pt had previously tested negative for allergies to egg and gelatin.
Medical Assistant gave an expired covid Pfizer Bivalent that was drawn at 3:28 pm on 6/26/2023  and was at room temperature. The Medical Assistant  asked another MA to get a Covid vaccine for a patient. The other MA did not check for expiration
Received shot approx between 11:00 to 11:30 am on 11/12/2018. Felt tired took a nap at 1:00 pm did not get up until 4:00 pm which was very unusual. Had severe sore throat, (lower part of throat).  Was afraid of throat closing. Gargled with salt water. Various aches and pains with the sore throat. Gradually getting better as of 11/15/2018.
Started feeling energized within a few hours of the shot. By 7pm that evening, the energized feeling became very uncomfortable and I was sensitive to noises. The energized feeling has continued since that time, although it is not currently as strong as it was during the first 4-5 weeks after the shot. At times, the feeling was extremely uncomfortable. This energized feeling has affected my sleep, making it difficult to fall or stay asleep.
This spontaneous report was received from a physician via a company representative concerning a 13 month old patient of unknown gender. On 22-MAY-2013, the patient was vaccinated with a dose of VARIVAX (Merck) (lot number and expiry date reported as H017377 and 15-SEP-2014 respectively, dose and route unspecified). Other suspect therapy included a dose of M-M-R II (lot number and expiry date reported as H010133 and 17-MAY-2014 respectively, dose and route unspecified) given on 22-MAY-2013. Concomitant therapy included hepatitis a virus vaccine (unspecified) given on 22-MAY-2013. On 24-MAY-2013, the patient was admitted to a hospital and was diagnosed with acute lymphoblastic lymphoma (previously reported as leukemia by the company representative). On 03-JUN-2013, the patient developed disseminated mild varicella rash on the trunk and extremities. The patient was still in the hospital. It was unspecified if the patient sought any medical attention. It was unspecified if any treatment was given or if any lab tests were performed. The outcome of the events was unknown. The relatedness for the events was unknown for VARIVAX (Merck) and M-M-R II. Additional information has been requested.
Immediate sensation of itchiness around site at left deltoid. Within minutes itchiness extended to arm, into neck area, then into other arm, then extended down into legs. With 10-20 minutes itchiness extended to trunk area, and to back of neck and head at about 40 minute mark. No redness or swelling noted anywhere. Vital Signs: Pulse Ox 99% room air, blood pressure 144/83, heart rate 70. Denied shortness of breath. Denied difficulty breathing.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On or about 28-APR-2009, the patient was inoculated with ZOSTAVAX (strength, dose, route, lot # and expiry date were not provided) by a physician as recommended for routine adult health maintenance for the prevention of shingles (prophylaxis). On an unknown date, the patient was diagnosed with shingles (herpes zoster) despite of vaccinating with ZOSTAVAX (vaccination failure). On or about 30-DEC-2014, the patient was treated for shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related.
Family arrived to office with 2 children (ages 2yr and 4mo) for well child visits.  The mom asked for flu vaccine for the 2yr old and nurse misunderstood and thought that request was for the 4mo old.  Vaccine given erroneously to the 4mos old patient.  Provider has discussed incident with family.
4MAY92 c/o hands aching, not feeling well also state had some swelling in hands; 12MAY92 states hand are back to nl now; no pain or swelling; taking antivert & an anti-inflammatory from MD;
All symptoms started about 5:00 pm 04.07.2022, HA, diarrhea, joint pain, fatigue, weakness, sore arm, weak, "fog" feeling
pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant) in a 35-year-old female patient (gravida 4, para 3) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 046A21A) for COVID-19 vaccination.     The patient's past medical history included Pregnancy (normal delivery, Live, full-term birth in 2010, 2012, 2016). Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for Prenatal care.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramedullar) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was in July 2020 and the estimated date of delivery was 28-Apr-2021. On 05-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  On 05-Mar-2021, EXPOSURE DURING PREGNANCY (pregnant) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound abdomen: inconclusive (Inconclusive) unremarkable ultrasound.         Patient reported taking prenatal vitamins. Patient estimated conception was in April.
Patients received expired doses; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received expired doses) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received expired doses). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients received expired doses) outcome was unknown. Not Provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug information was provided. Patient received second booster dose of Moderna vaccine. No treatment drug information was provided.
Vaccine thawed for only 45 minutes; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine thawed for only 45 minutes) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported. ).    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine thawed for only 45 minutes). On 08-Mar-2021, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine thawed for only 45 minutes) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This report refers to a case of wrong technique in product usage process for mRNA-1273, lot # 027A21A with no associated AEs.   Reporter did not allow further contact; Sender's Comments: This report refers to a case of wrong technique in product usage process for mRNA-1273, lot # 027A21A with no associated AEs.
Initial report was received on 07 March 2012 from a health care professional. A two-month-old male patient had received on 02 March 2012 the following vaccines: a first dose intramuscular right thigh injection of PENTACEL, lot number C4061AB; dose two intramuscular left thigh injection for Hep B, lot number 1482AA (manufacturer not reported); a first dose intramuscular left thigh injection of PREVNAR 13, Pfizer lot number 918172 and a first oral dose of Rotavirus, lot number 1457AA (manufacturer not reported) and 24 hours after vaccination, experienced uncontrollable crying, increased swelling, redness to the right thigh and the area was hot to the touch. The patient was taken to the ER (emergency room) and was hospitalized for two days for observation. Laboratory findings included an increased white blood cell count (wbc). The patient's diagnosis was "cellulitis versus allergic reaction". Treatments were not reported. No further information was available at the time of the report. The patient's outcome was recovered (date not reported). Documents held by sender: none.
Patient has swelling in arm, redness, and heat. She is also experiencing difficulty breathing. All are signs of an allergic reaction.
Syncope, responsive after < 30 seconds. Stable vital signs. Contusion (R) forehead. To ER with c/o blurred vision. Client reports released from ER after normal findings on CT scan of head.
Major headache primarily on left side of head, nausea, vomiting, fatigue started when I woke up at 8 am and experienced all day. Stayed in bed all day. Lack of appetite
Developed Shingles two weeks after shot. Shingles right side of upper chest to back. Took ACYCLOVIR 800MG BY MOUTH 5 times daily for 12 days. Successfully recovering.
Administered expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine) in a 65-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine). On 22-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication provided. No treatment information was provided.  Reporter stated that the vaccines were stored in freezer and they took out one to two vials and placed in fridge each day as needed.
Increased bp, diaphoretic, skin turned red, pins and needle sensation,  increased heart rate , swollen lower lip, nauseated, weird sensation of not feeling right almost like out of body
Vaccine received at 1:30 pm.  At approx 7 pm my mother sat in chair at table and was unable to get up or walk for over an hour. She was leaning sideways in her chair. Paramedics had to carry her to gurney as she could not stand or walk on her own. Taken to ER and observed overnight. Was able to walk with walker within a few hrs and back to normal strength next day.
I had severe diarrhea, 6-7 times a day for 4 months. Terrible stomach cramping and pain in the abdomen from the pressure. Still have stomach pain every night feeling my bowels working. Resulted in aggravating my lower back which was already weak and to date have chronic back pain.
5 by 6 cm area of erythema/induration on right antero/lateral thigh
Woke up day after immunization noticed redness around injection site. Area is red, warm to touch, and tender. 24 hours after onset, area of redness has spread.
Headache, Runny nose, cough, mucus, light fever, body aches, sneezing.
Information has been received from a licensed practical nurse (LPN) concerning a patient who was vaccinated with a dose of Rotateq. The LPN reported that the patient subsequently developed diarrhea. It was unknown if medical attention was sought. At the time of this report, the outcome was unknown. No further information is available.
Approximately 20-30 minutes post vaccine, he developed itching, a rash on his arms and legs. His sclera became inflamed, eyelids swollen. Nose runny and eyes were watery. No difficulty breathing, or swallowing and no vomiting. His symptoms resolved fairly quickly with oral BENADRYL. We do not have his previous records, but mom reports he has had one every year due to a history of asthma.
Acute onset neurologic deterioration with ascending paralysis to T7. Numbness, weakness weakness arms. Flaccid paralysis both lower ext resolving. Continues with problems in coordination, difficulty walking impaired balance.
This is a Physician reporter who is willing to provide further information  if needed. The day of the vaccine I started to have tightness like a Broncho Spasm in my chest 30 minutes after the vaccine.. My co-workers told me I was flushed. I was a little short of breath and my pulse was elevated.  It seemed to improve after a little time. I started to feel worse on 01/12/2021. Ten days after the vaccine I tested positive on 01/14/2021for Covid-19. I had serious symptoms with the Covid-19. After five months I have been unable to work as a Physician and I am still having. I recently got tested for Polyethylene Glycol and I tested positive on a skin test. I am unsure whether to get the second dose. I also have headaches and memory defects muscle aches weakness and a weak left arm. My headaches happen daily and they vary in severity. I am scheduled to have a Bifrontal MRI tomorrow. I started to have problems with concentration within a week of the vaccine and I am still having problems with that. I experience muscle and body aches as well as neck and shoulder problems. My energy level is improved but still very low. I am scheduled to see a Neurologist. My left arm is very weak from the shoulder to the forearm since that time Radiculopathy.
APPROXIMATELY 18 MINUTES AFTER RECEIVING COVID VACCINATION, PATIENT REPORTED SHORTNESS OF BREATH AND SENSATION OF THROAT CLOSING. PHARMACIST ADMINISTERED 50MG DIPHENHYDRAMINE PO AND 0.3MG EPINEPHRINE IM TO RIGHT DELTOID @ APPROXIMATELY 5:15PM. PHARMACIST MONITORED PATIENT UNTIL EMS ARRIVED AT APPROXIMATELY 5:22PM. PATIENT REMAINED CONSCIOUS THROUGHOUT EVENT, BUT DID EXPERIENCE MILD TACHYCARDIA (HR<120) AFTER EPINEPHRINE.
Shingles, 2 weeks after my 2nd covid shot In addition I developed what felt like chronic sore muscles.  I was treated for tendinitis in my right rotator cuff, but during physical therapy my left arm and shoulder began permanently hurting also.   A blood test indicated "some connective tissue disease"., said my doctor.  A year after my 2nd covid shot I still have sore shoulders and upper arms, stiff wrists, diminished range of motion.  Shingles lasted 6 weeks and has not returned so far.
COVID-19 infection; COVID-19 infection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 13Apr2021 as dose 1, single (Lot number: EP7533), in left arm and on 04May2021 as dose 2, single (Lot number: EN6198) at the age of 49 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), on 03Dec2021 as dose number unknown (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Overweight" (unspecified if ongoing). Concomitant medication(s) included: DULOXETINE; PHENTERMINE; ALLEGRA. Patient received the vaccine. Patient received the other medication in 2weeks included duloxetine, phentermine and allegra. No known allergies. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19 infection". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results, notes: COVID 19 Treatment; (23May2022) Negative, notes: tested negative on day 5 after taking paxlovid; (27May2022) positive, notes: Tested positive for covid on day 9. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: Adverse event Covid Rebound after Paxlovid. Tested negative on day 5 after taking Paxlovid. Tested positive for covid on day 9 with symptoms including Congestion, sore throat and sinus pain. Anti-viral details: COVID 19 Treatment, Paxlovid, treatment start date was 18May2022 and treatment stop date was 22May2022.  No follow-up attempts are possible. No further information is expected.
12/12/17: DAY OF VACCINE, LEFT ARM WAS RED AND SORE. PATIENT HAD HEADACHE AND WAS NAUSEATED. 12/13/17: THE MORNING AFTER, BLURRED VISION, NAUSEA/VOMITING, HEADACHE MORE SEVERE, DIZZINESS AND CHILLS. SWOLLEN ARM AND REDNESS PERSISTS EVEN UNTIL 12/15/17.
69 expired doses administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (69 expired doses administered) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (69 expired doses administered). On 10-Jan-2022, EXPIRED PRODUCT ADMINISTERED (69 expired doses administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant  and treatment medications were reported.
Tdap given 7-22-08. Mom called office 7/28/08. Had hives and difficulty breathing on 7-24-08 - Went to ER whop called vaccine company - Could delayed reaction per them
Patient reports being "violently ill" the evening after receiving INFLUENZA vaccine. Patient reported vomiting.
BUD Date 4/7/2022 administered   04/10/2022.Pfizer could not provide stability information beyond 04/09/2022 and recommended another booster given 05/04/2022
fever greater than 105-took several days (72hrs) to resolve (had run temp previously but APAP always brought it w/in nl range using APAP w/inc dosage & tepid sponge bath
Received MMR 9\13 9:30 am.  By 12 noon started to experience a sore neck. By evening sore neck had progressed to muscle spasms requiring vicodin for sleep.  I awoke 2am with severe spasms.  Thursday am the spasms had slightly subsided allowing me to work but by 6 pm I had full muscle spasms from base of neck to middle of upper shoulders.  The muscle spasms continued through the night and into the morning.  9/15 am I arose with a temp  of 99.1, weakness, slight nausea, sore neck anteriorly and posteriorly with posterior muscle spasms.  I notified HR and was subsequently seen in the ER and given the diagnosis of "torticollis" an adverse reaction to MMR immunization.  I was given valium and Ibuprofen and placed on leave from work until muscle spasms subside.
Fever (101.1), Chills, Aches, Nausea, and Fatigue.
Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Medium, Systemic: Lymph Node Swelling-Medium
pt recv vax 10AM 20OCT97 & 1150 pt reported to school nurse, c/o sore lt arm;lt arm noted to be swollen the entire arm, vs 78/50, T98.1-80-16;lt arm inc pillow-swelling dec;
Had vaccines during day on 1/8/15. Later that evening he felt warm and had episode of screaming, shaking arms over head and jerking. Did not respond to parents for 10 minutes. By time they were at ER was back to normal. Sounds like night terror, doubt febrile seizure, reported because of time relationship to immunization.
Day one: approximately 6 hrs post 01:13 pm injection fever, chills, lethargy.  Took 500 mg Tylenol extra strength and symptoms gone within 4 hrs. Day Two: sore injection site.  Took 400mg Advil 2x?s q 6 hrs Day Five: in the pm developed ver sore, tender, deep pain on left axillary region. No swelling evident. Pain transferred to outer upper arm.  Red, blotchy area at deltoid injection site. No hives or itching.  Day Six : deep, tender, pain still persists unilaterally, left axillary region. No swelling evident.  Took 400 mg 2?xs  q 6hrs to control pain.
Flare up of Long COVID-19 symptoms. This was a twitch in my right thigh that got progressively worse leading to a burning sensation in 3 distinct places. Doctor referred to a Physical Therapist at the time of reporting, no appointment has been made as it happened same day as report.
This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after expiration date), PRODUCT STORAGE ERROR (Vial was expired on 13-May-2022, placed in the refrigerator on the same day of administration (26-May-2022)) and NO ADVERSE EVENT (No adverse event) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003K21-2A, 034F21A, 011A21A and 031L20A) for COVID-19 prophylaxis. The patient had never been diagnosed with/ tested positive for COVID-19. Acute illnesses at the time of vaccination and up to one month before were unknown. Chronic or long-standing health conditions were unknown. Concurrent medical conditions included Penicillin allergy, Drug allergy (Aspirin) and Drug allergy (Sulfate). On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 18-Nov-2021 at 6:20 PM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 26-May-2022 at 2:58 PM, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 26-May-2022 at 2:58 PM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was expired on 13-May-2022, placed in the refrigerator on the same day of administration (26-May-2022)) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after expiration date), PRODUCT STORAGE ERROR (Vial was expired on 13-May-2022, placed in the refrigerator on the same day of administration (26-May-2022)) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related and EXPIRED PRODUCT ADMINISTERED (Dose administered after expiration date) to have an unknown relationship. No further causality assessment was provided for PRODUCT STORAGE ERROR (Vial was expired on 13-May-2022, placed in the refrigerator on the same day of administration (26-May-2022)). Concomitant product use was not provided by the reporter. The event did not cause the patient to seek medical care. It was unknown if there was any other potential causes. It was unknown if the patient experienced a similar event in the past. The vial did not undergone any temperature excursions. Treatment information was not provided.
Patient described vomiting, fatigue, and a headache lasting 24 hours following the vaccination. However she also did start MOBIC for the first time shortly after receiving her vaccine and it's possible the reaction is due to MOBIC.